Clinical Trials
What You Need to Know
Imalia will launch a Phase 2 study in 2026
Trial Locations: USA, Europe, Middle East, India
- Enrollment Start Date: Q2 2026
- Eligibility Criteria: patients above 12
- Trial Goals:
- Safety and tolerability
- VOC
- Anemia
- Quality of life
Stay Informed
Sign up for updates on trial progress, publications, and results as we continue to advance our research.